articleTop 1% cited
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
European Urology · 2013 · Vol. 65(2) · pp. 467–479
Axel Heidenreich✉Patrick J. Bastian(Paracelsus-Klinik Golzheim Düsseldorf)Joaquim Bellmunt(Hospital Del Mar)Michel Bolla(Centre Hospitalier Universitaire de Grenoble)Steven Joniau(KU Leuven)Theodor van der Kwast(Erasmus MC)Malcolm Mason(Velindre Cancer Centre)Vsevolod Matveev(Russian Academy of Sciences)Thomas Wiegel(University Hospital Ulm)Filiberto Zattoni(Ospedale Santa Maria della Misericordia di Udine)Nicolas Mottet(Centre Hospitalier Universitaire de Saint-Étienne)
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentHormonal and reproductive studiesProstate cancerDocetaxelAndrogen deprivation therapyProstatectomyAbiraterone acetateRadiation therapyTestosterone (patch)Prostate-specific antigenSalvage therapy
MeSH terms
HumansKallikreinsMaleNeoplasm Recurrence, LocalProstatectomyProstatic NeoplasmsRadiotherapyTime FactorsTreatment OutcomeProstate-Specific AntigenDisease ProgressionAntineoplastic Agents, HormonalProstatic Neoplasms, Castration-Resistant
Citations
1,348
FWCI
118.71
field-weighted impact
References
86
Percentile
100%
vs. same field & year
Citations per year
Cited by
Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
European Urology · 2016 · 997 citations
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
European Urology · 2016 · 1,439 citations
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
The Journal of Clinical Endocrinology & Metabolism · 2018 · 1,533 citations
References
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
International Journal of Radiation Oncology*Biology*Physics · 2006 · 2,705 citations
Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer
JNCI Journal of the National Cancer Institute · 2004 · 1,199 citations
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
Journal of Clinical Oncology · 2008 · 2,225 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.